Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data

Johannes Wendl (), Andreas Simon, Martin Kistler, Jana Hapfelmeier, Antonius Schneider and Alexander Hapfelmeier
Additional contact information
Johannes Wendl: Technical University of Munich
Andreas Simon: Vilua Healthcare GmbH
Martin Kistler: Vilua Healthcare GmbH
Jana Hapfelmeier: Vilua Healthcare GmbH
Antonius Schneider: Technical University of Munich
Alexander Hapfelmeier: Technical University of Munich

Applied Health Economics and Health Policy, 2023, vol. 21, issue 3, No 10, 477-487

Abstract: Abstract Background and Objective Despite the importance of medication adherence for chronically ill patients and the vast literature on its relationship to costs, this field suffers from methodological limitations. These are caused, amongst others, by the lack of generalizability of data sources, varying definitions of adherence, costs, and model specification. We aim to address this with different modeling approaches and to contribute evidence on the research question. Methods We extracted large cohorts of nine chronic diseases (n = 6747–402,898) from German claims data of stationary health insurances between 2012 and 2015 (t0–t3). Defined as the proportion of days covered by medication, we examined the relationship of adherence using several multiple regression models at baseline year t0 with annual total healthcare costs and four sub-categories. Models with concurrent, and differently time-lagged measurements of adherence and costs were compared. Exploratively, we applied non-linear models. Results Overall, we found a positive association between the proportion of days covered by medication and total costs, a weak association with outpatient costs, positive with pharmacy costs, and frequently negative with inpatient costs. There were major differences by disease and its severity but little between years, provided adherence and costs were not measured concurrently. The fit of linear models was mainly not inferior to that of non-linear models. Conclusions The estimated effect on total costs differed from most other studies, which highlights concerns about generalizability, although effect estimates in sub-categories were as expected. Comparison of time lags indicates the importance of avoiding concurrent measurement. A non-linear relationship should be considered. These methodological approaches are valuable in future research on adherence and its consequences.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-023-00797-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:21:y:2023:i:3:d:10.1007_s40258-023-00797-6

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-023-00797-6

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().